Showing results (1631-1640 of 4,521) with videos related to

Sort By:
Pageof 453
Future Oncology (London, England)|March 25, 2006
BRCA2 in mitotic exit: a new role in regulating genomic stabilityXiaoxing Wang, Wei Dai
Future Oncology (London, England)|March 25, 2006
Targeting the ubiquitin-proteasome pathway in breast cancer therapyE Claire Dees, Robert Z Orlowski
Future Oncology (London, England)|March 25, 2006
Current developments in adenovirus-based cancer gene therapyDaniel T Rein, M Breidenbach, David T Curiel
Future Oncology (London, England)|March 28, 2006
The role of p53 mutations as a prognostic factor and therapeutic target in inflammatory breast cancerCharles H Yang, Massimo Cristofanilli
Future Oncology (London, England)|November 12, 2009
Role of prolonged mitotic checkpoint activation in the formation and treatment of cancerW Brian Dalton, Vincent W Yang
Future Oncology (London, England)|November 12, 2009
Fetal cell microchimerism in cancer: a meaningful event?Kiarash Khosrotehrani, Selim Aractingi
Future Oncology (London, England)|November 12, 2009
Urokinase plasminogen activator system as a potential target for cancer therapyAhmed H Mekkawy, David L Morris, Mohammad H Pourgholami
Future Oncology (London, England)|October 17, 2022
Remote consultations: experiences of UK patients with prostate cancer during the COVID-19 pandemicRebecca Leszczynski, Natalia Norori, Steve Allen, et al.
Future Oncology (London, England)|June 13, 2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCCJean-Pascal Machiels, Jérôme Fayette, Robert Haddad, et al.
Future Oncology (London, England)|June 10, 2025
The rules of different B cell subtypes in colorectal cancer: friends or foes?Yuanchao Shi, Qianwen Luo, Jingwei Duan, et al.
Pageof 453